LYCOS RETRIEVER 
Dental
built 640 days ago
Cancer patients receiving intravenous bisphosphonate drugs should not be treated with invasive dental procedures. Novartis Pharmaceuticals Corp. stated that osteonecrosis of the jaw (ONJ) has been observed in cancer patients who are receiving Aredia or Zometa-bisphosphonates used to treat complications of advanced cancer known as "hypercalcemia of malignancy," bone metastases from solid tumors and other conditions
Source:
MORE ABOUT
States